Summary
This Form 8-K filing from WellPoint, Inc. (now Elevance Health) on June 11, 2013, primarily serves to disclose information that officers expect to share with securities analysts and investors during meetings scheduled between June 11 and June 28, 2013. The most critical piece of information for investors is the reaffirmation of the company's full-year 2013 net income per share guidance. WellPoint reiterated its expectation for full-year 2013 net income per share to be at least $7.75. This guidance includes a previously recognized net investment loss of $0.05 per share from the first quarter of 2013 and does not anticipate any further net investment gains or losses for the remainder of the year. This reaffirmation suggests the company was on track with its previous financial projections at that time.
Key Highlights
- 1WellPoint, Inc. reaffirms its full-year 2013 net income per share guidance of at least $7.75.
- 2The guidance includes a pre-existing net investment loss of $0.05 per share from the first quarter of 2013.
- 3No further net investment gains or losses are anticipated for the remainder of fiscal year 2013.
- 4This disclosure was made in connection with meetings between WellPoint officers and securities analysts/investors.
- 5The meetings were scheduled to occur from June 11, 2013, to June 28, 2013.
- 6The report includes a standard Safe Harbor Statement regarding forward-looking statements and associated risks.